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Summary.-Plasma membranes isolated from two immunogenic, non-cross-
protecting, MC sarcomas were shown to retain the specific rejection antigens of
whole cells as well as serologically detected H-2 antigens. Solubilization of the
membranes with sodium deoxycholate gave quantitative release of H-2 and retained
the rejection specificity of the tumour from which it was derived. Polyacrylamide-gel
electrophoresis (PAGE) showed no extensive degradation of membrane com-
ponents during solubilization.
The solubilized TSTAs were further characterized and purified on columns of 4
different lectins immobilized on sepharose beads. TSTA from both tumours bound
to WGA but not to Con A, LCH or RCA columns. Specific activity was retained after
elution from the WGA column. Serologically detectable H-2 bound to the Con A and
LCH columns only. Clear separation of H-2 from TSTA activity was thus obtained.
Furthermore the WGA-binding material represents a source for further purification
of TSTA molecules in order to explore the basis for their diversity.
METHYLCHOLANTHREN,E-INDUCED (MC)
SARCOMAS in mice often possess unique
tumour-specific transplantation antigens.
These antigens are demonstrated by pro-
tection assays in which mice, immunized
with one tumour, are subsequentially
challenged with the same or a different
tumour. Such assays have in general
failed to reveal sharedspecificities (Basom-
brio, 1970). The molecular nature of
tumour-specific transplantation antigens
(TSTA) and the genetic basis for their
diversity is an intriguing biological puzzle.
Wliether the diversity results from varia-
tions in a similar molecule or from the
expression on the tumour-cell surfaces of
various unrelated molecules is unknown.
One of the major obstacles to the charac-
terization of TSTA has been the failure to
prepare the antigens in high yield, in an
undearaded soluble form suitable for
purification, that retains specificity in
transplantation assavs. All these require-
ments must be met if we are to know the
nature of the diversity of TSTA.
Many investigators have shown that
mechanically dissociated tumour cells
retain some of the antigenic properties of
the intact cells (Oettoen et al., 1968;
McCollester, 1970)_ Except in a few
instances (Holmes etal., 1971)transplanta-
tion immunooenicity with a set of related
tumours was not measured. With material
solubilized from tumour cells by various
techniqties, such as extraction with 3m
KCI (Meltzer et al., 1972), with NP40
(Siegert et al., 1.977) orby papaindigestion
(Law et al., 1976), assays other than trans-
plantation immunogenicity were usually
used.
Pellis & Kahan (1975) showed trans-
plantation-specific activity of material
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extracted with 3m KCI from several MC
tumours of C3H mice. However, the
extracted material was weakly immuno-
genic, and was effective only in a narrow
dose range. Until recently the techniques
that have been successful in solubilizing
and purifying major histocompatibility
antigens (Henriksen et al., 1978) have been
little used to purifv tumour-specific anti-
gens. Natori et ai'. (1977) have clearly
shown that the TSTA of Meth A sarcoma
cells can be solubilized in an immunogenic
form using Nonidet P40.
In this paper we show that TSTA from
two immunooenic non-cross-reacting MC
fibrosarcomas from a BIO mouse can be
solubilized from a membrane preparation
by sodium deoxycholate in the presence of
an inhibitor of proteolysis. These soluble
preparations are immunogenic in vivo
and retain the individualspecificities ofthe
cells from which they were derived. That
the technique is efficient in solubilizing
other membrane compoiients is shown by
the release of H-2. Analysis of the solubil-
ized material by polyacrylamide gel elec-
trophoresis (PAGE) showed little evidence
ofdegradation of either proteins or glyco-
proteins. Theapproacl-i used for the further
purification of TSTA was based on the
assumption that TSTAs would be carried
on glycoproteins. Plant lectins bind speci-
fically to certain sugars in the side chains
of glycoproteins, and are useful tools for
analysing and purifying cell-s-Lirface mole-
cules (Sharon & Lis, 1972). Lectins
immobilized by covalent coupling to
columns of Sepharose beads are efficient
at glycoprotein separation and can be
used in the presence of low concentrations
of detergents (Lotan et al., 1.977). Such
columns have been successfully used in
the purification of membrane components,
including H-2 and la antigens (Bridgen
et al., 1976), carcinoembryonic antigens
(David & Reisfeld 1974), and synaptic
membrane glycoproteins (Gurd & Mahler,
1974). Tf TSTA could be shown to bind to
a lectin column, it could be considerably
purified by a single procedure. In this
paper we investigate the behaviour of
bothTSTA and H-2 from MC sarcomasolu-
bilized membranes on columns of 4 dif-
ferent immobilized lectins.
MATERIALS AND METHODS
Tumours
These were induced by s.c. injection of
0-5 mg of 3-methylcholanthrene (Eastman-
Kodak) in trioctanoin into both hind limbs
of the mouse. A group of 12-16-week-old
C57BL/10ScSn (BIO) mice bred in our
animal house from breeding stock of the
Laboratory Animal Centre (Carshalton) was
injected in this way. Primary tumours de-
veloped within 120 days in 80% of the in-
jected sites. The tumours NA-ere excised and
passaged tA,,ice s.c. Cell suspensions were
made byincubatingfinelychopped tumour in
0-25% trypsin in Ca and Mg-free Eagle's
medium for I h at 37'C with continuous
stirring. The cells were filteredthrough sterile
muslin,washed and stored inliquidN2in 10%
foetal calf serum (Gibeo Biocult, Paisley,
Scotland) and 10% dimethyl sulphoxide in
RPMI 1640 containing 100 iu/ml penicillin
and 100mg/ml streptomycin (Flo", Labora-
tories, Trvine, Scotland). They m-ere used later
for further passages in vivo. All experiments
were performed on tumours betAveen in vivo
Passages 3 to 8.
Immunogenicity a88ays
Mice Avere immunized either by excision of
growing tumours or by several injections of
irradiated cells or material solubilized from
cell suspensions. To immunize by excision,
tumours NA,,ere grown from 106 viable cells
given s.c. in the left flank 10days earlier. Ten
days after excision, a challenge dose of
105-106 cells was given s.c. to the right groin
in groups of 4 immunized and 4 control mice.
The relative growth rate of the subsequent
tumours in the 2 groups of mice was deter-
mined by measuring with calipers the maxi-
mum tumour diameter, one at ri-aht an les to
that and calculating the mean tumour
diameter.
Some tumours showed a considerably re-
duced growth rate in the immunized group.
Otherimmunogenicity assays were performed
bygiving 3 weekly s.c. injections of either 107
irradiated cells (10,000 R) or an amount of
subcellular material equivalent to 4 x 10 7
cells in absorption of an ttnti H-2b serum.833 SOLUBILIZATION AND LECTIN BINDING OF SARCOMA TSTA
Immunogenicities were compared by calcu-
lating the antigenic ratio (Basombrio, 1970)
defined by
mean tumour diameter in unimmunized mice
mean tumour diameter in immunized mice
measured 16 days after challenge. All mice
grew tumours. Standard errors of the mean
were calculated.
From a group of 17 fibrosarcomas, 2
tumours, MC6A and MC6B, arising from
opposite limbs of the same mouse, were
selected as the most antigenic. Electron-
microscopic appearance, histological appear-
ance, growth rates in vivo and in vitro, and
cell-cycle kinetics studied by pulse cyto-
photometry, were similar for both.
Serological method8
H-2.-The amount of H-2b on cells and
subcellular preparations was determined by
mixingsuitably diluted anti-H-2b sera (Searle
BIOBR anti-BIO) with doubling dilutions of
the material to be tested and assaying
residual cytotoxicity on BIO lymphnode cells
labelled with sodium [51Cr] chromate (Radio-
chemical Centre, Amersham). After pre-
liminary titration of antiserum, a dilution
giving an amount of cytotoxicity falling on
the shoulder ofthe titration curve was chosen
for the absorption experiments. Pooled
guinea-pig sera (final dilution 1/16) was used
as a complement source. For absorption,
50 /A of the various dilutions of the material
for H-2 assay were incubated with 50 tLI of
antiserum for 60 min at room tem'erature in
a plastic tube (Luckham, LP3). All dilutions
were made in Earle's balanced salt solution
containing 10mm HEPES and 0-8% BSA.
After spinning for 5 min at 2000 rev/min,
50 tLI supernatant was removed and added to
50 /A medium containing 5 X 104 5lCr-
labelled target cells in a separate tube. After
30 min incubation at room temperature and
subsequent centrifugation, the supernatants
were removed and 50 tLI of complement
added. The cells were mixed and left at room
temperature for 60 min. Lysis was terminated
by the addition of2 ml ofcold PBS, and after
centrifugation I ml was removed for assay of
released 51Cr. Results were expressed as a
percentage of maximum releasable counts
determined by incubating the target cells in
4-5% Brij. Relative amounts of H-2 in
different samples were then estimated from
the titration curves. To check the specificity
of anti-H-2 absorption, similar assays were
performed on solubilized material using anti-
H-2k (Searle BIO anti-BIOBR) serum.
Polyacrylamide-gel electrophoresi8 (PAGE)
Samples were prepared and run according
to the method of Laemmli (1970). The acryl-
amide concentration was 10% and samples
were reduced with 1% P-mereaptoethanol
before running. Gels were stained for protein
by immersion in Coomassie Blue and de-
stained with 50% methanol:7% acetic acid.
The same gels were then stained for glyco-
proteins with 1251-concanavalin A (Con A)
(Robinson et al., 1975). Afterbeing de-stained
for Coomassie Blue the gels were equilibrated
with 100mm Tris HCI,pH 7-5, lmmCaC12 and
Imm MnC12. The equilibrated gels were then
immersed in a bath containing 500 ml of the
above buffer with 0-5 mg 1251-Con A (Phar-
macia Fine Chemicals, Uppsala; 107 ct/min)
and 5 mg cytochrome C (Sigma, London).
After 12 h at 4'C withgentleshaking, thegels
were washed x 3 with equilibration buffer,
dried on to filter paper and autoradio-
graphed directly. Glycoproteins were visible
after , 16 h autoradiography.
Membrane isolation and solubili8ation
Two x 109 sarcoma cells were prepared in
suspension as described above from ,30 g of
in vivo-grown tumour. These cells were 100%
viable as judged by Trypan-blue exclusion.
After washing x 3 in PBS the cells were sus-
pended in 40 ml of a hypotonic buffer (10mm
Tris HCI, pH 7-5, containing 0-Imm phenyl-
methyl sulphonyl fluoride (PMSF)) to inhibit
endogenous protease activity. After standing
on ice for 30 min, the cell suspension was
given 20 strokes in a Douncehomogenizer and
spun at 108,000 g for I h at 4'C in a swinging-
bucket centrifuge on a layer of45% sucrose.
The membrane fraction layered on top ofthe
sucrose and was collected, resuspended in
O-Olm phosphate-buffered saline (PBS) and
pelleted by centrifu'ation for 30 min at
108,000 g. Thepellet was broken bypipetting
with a Pasteur pipette and dissolved in 2 ml
of 1% deoxycholate (DOC) in O-Olm PBS
containing 0-Imm PMSF. After 2 h ofgentle
mixing at 4'C, 2 ml ofO-Olm PBS was added,
bringing the DOC concentration to 0-5%.
This mixture was spun for 30 min at 108,000 g
and the supernatant harvested.834 K. SIKORA, G. KOCH S. liRENNER AND E. LENNOX
Rentoval ofDOC
The supernatant was dialysed in 17isking
tubing 8-1/32 at 4'C for 48 h with 3 changes
in the dialysate (0-01m PBS and 0-Imm
PMSF). This was effective in removing most
of the DOC present, and made the prepara-
tions suitable for the biological assays. The
effective removal of DOC was demonstrated
by follo-vA,ing the radioactivity released from
the dialysis bag after the addition of a trace
amount of 14C-labelled DOC (Radiochemical
Centre, Amersham). The removal of DOC
caused aggregation, as demonstrated by a
cloudy precipitate. The -N.,hole preparation
was used for immunization. The resultant
membrane and deoxycholate-solubilized
(DOCSOL) preparations were stored in
aliquots at 20'C and used Avithin one month
ofproduction. A summary of the production
process appears in Fig. 1.
30 g Fresli tumour
Ti-ypsinize
2 x 109 Cells in suspensioil
1-testispend in 40 ml liypotoiiie btiffer with 1),118F
O'C 30 min
Homogenize
Spin 108,000 g VC 60 min on sticrose cusliioil
Harx-est membranes at interface
NA'ash in 0-01m phospliate saline (PBS)
108,000 g VC 30 min to pellet
11
Take up in 1% DOC in PBS
Agitate 2 h
Add PBS to obtain 0-5% DOC
Spin 108,000g, VC 30 min
Supernatant Pellet
Dialyse 60 h
against PBS + P]NISF
Assay Stoi-e at -20'C
FIG. I.-Preparation and (teoxycliolate solu-
bilization of tumour membranes.
Lectin columnpreparation
Concanavalin A (Con A), ,A,heat germ ago,lutinin (WGA: Pharmacia FineChemicals, Uppsala, Sweden), Ricinu8 communi-s agglu- tinin (RCA: Miles Laboratories, Stoke Poges) and Len8 culinari8 haemagglutinin (LCH, prepared from lentilsby therecipe ofHoward
etal.(22)) Alere coupled to cyanogen-bromide-
activated Sepharose 4B (Pharmacia Fine
Chemicals, Uppsala). Tno g ofSepharose-4B
cyanogen-activated gel was swollen and
,vN,ashed for 15 min in 500 ml Imm HCI
on a sintered glass filter. 10-50 mg of
the lectin to be coupled Nvas dissolved
in 10 ml of the coupling buffer (0-Im
NaHCO3, O-5m NaCl, pH 8-3), which in-
cluded 2% of the specific sugar recognized
by the lectin. The washed, swollen gel -was
added to the coupling buffer and mixed for
2 h at room temperature (19'C). Unbound
material was washed away with coupling
buffer and any remaining active groups were
reacted with Im ethanolamine (pH 8-0) for
I h. Three washing cycles were used to re-
move non-covalently absiorbed protein, each
cycle consisting of a wash at pH 4.0 (0-Im
sodium acetate, I-Om NaCI) followed by a
wash in coupling buffer. This procedure pro- duced the binding of70-80% of the lectin to
the Sepharose as estimated from the optical
density at 280 nm (OD 280) of added and
unbound lectin.
Runningofcolumim
Five ml of washed lectin-coupled gel -%N,as
loaded into a plastic syringe on top of a small
piece of glass wool. The column -%i-as equili- brated with loading buffer (O-01m NaHPO4,
10-5M CaC12, 10-5M MnC12, 0-Imm PMSF,
0-85% NaCl, 0-2% DOC, pH 7-3) and run at
25'C. DOCSOL was loaded in a 2 ml volume
and allo.,A-ed to equilibrate for 30 min. The
column was then washed with loading buffer
until no further protein (determined by OD
280 of the effluent) N.,,as detected. Three
n,ashings, containing unbound components,
were pooled. The eluting buffer, containing 2% of the sugar binding specifically to the
lectin ((x-methyl mannose for Con-A and
LCH, N acetyl glucosamine for WGA and
D-galactose for RCA) -was then run into the
column. After 30 min equilibration the
column was washed with eluting buffer and
again the washings collected and pooled (boundfraction).
Duplicate columns of Con A. LCH, RCA
and WGA-coupled sepharose were prepared and used to remove glycoproteins from
BIO/MC6A and 6B DOCSOL respectively. Columns were loaded -%Nith 2 ml DOCSOL
prepared from 109 cells. Bound and unbound
fractions were collected, dialysed for 48 h
against O-Olm PBS and concentrated bySOLU131LIZATION AND LECTIN BINDING OF SARCOMA TSTA 835
vacuuiii dialysis. Aliquots (0-1m) were re-
moved for estimation of OD 280, H-2b, and
for running on SDS-PAGE. The remainder
NN,as divided into 3 portions and stored at
-20'C. Later groups of 3 BIO mice were
immunized by 3 -weekly s.c. injections of
0-2 ml of each stored fraction into the right
groin and challenged 10 days after the last,
immunization AN-ith 105 MC sarcoma cells.
RESULTS
H-2 relea8e
The relative amount of H-2b released,
as determined by inhibition of a BIOBR
anti-BIO (anti-H-2b) lymphocytotoxic
serum, is shown for MC6A cells in Fig. 2.
100
c' 50
CELLS MEM DOC 1 2 3 4
Fm. 2.-H-21) released fi-om AIC6A cells by membrane solubilization. Tiie total amouiit
of H-2b is expresse(I in relation to the
absoi-ption capacity of the membranes
( I 0) These absorptioiis wei-e performe(i by using the amount of membranes oi-
DOC-solubilize(I matei-lal produced fi-om
107 cells after dialysis to remove DOC. Tlie,
pellet remaining aftet- centrifugation was
taken up in a ftirtlier volume of I% DOC III
O-Olm PBS an(I spun agairl foi- 30 min at
108,000 g. Supernatant was remox-ed aii(i
an absorptioii assay performe(i (DOC 2). The pellet was again taken up in I% DOC
an(i the process repeate(i twice (DOC :3
and 4).
For reasons not undei-stood, preparation of membranes from cells apparentlv in-
creased the amount of antigen available
to absorb anti-H-2 activity. A single extraction of these membranes with DOC
releases the H-2b absorption equivalent of that of intact cells. Further DOC
extraction of the tindissolved iiiaterial
solubilizes onlv small additional amounts
of H-2. For this reason onlv one DOC
extraction was performed. That MC 6A
DOCSOL was unable to absorb an anti-
H-2k serum indicates the specificity of
DOC-released material.
Characterization of the 80lubilized
membrane8 on acrylamide qels
Fig. 3 shows a comparison of the pro-
teins and glycoproteins (Con A-staining
proteins) in the materialduring the various
stages of solubilization. The majority of
theproteins from the whole-cell extract are
not in the membranepreparation. Further-
more, solubilization of the membranes
results in the removal of several other
major proteins from the preparation. In
contrast the glycoprotein profiles of the
membranes and the DOCSOL are very
similar, showing that solubilization of
glycoprotein is efficient. Comparison ofthe
protein profiles of the preparations shows
i:l,:F-`:. a -
... I
Fla. 3.-Polyacrylamide-gel electi-oplioresis of MCM cells (1), membranes (2) an(i
DOCSOL (3). Staining by Coomassle bltio
or 1251 Con-A.836 K. SIKORA, G. KOCH, S. BRENNER AND E. LENNOX
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CELLS OR CELL EQLJIVALENTS(x161)
FIG. 5.-Response to varying doses of
irradiated cells or DOCSOL from BIO
MC6A after I or 3 weekly immunizations.
of either MC6A or 6B origin. The dose-
response curve for immunization with
either cells or IDOCSOL is shown in Fig. 5.
It can be seen that membranes and the
soluble material are immunogenic, al-
though less so than whole cells. This may
reflect loss during the extraction process
or the weaker immunogenicity of the sub-
cellular preparations. The specificity be-
tween MC6A and 6B is maintained in
these preparations.
Lectin colitmn fractionation
H-2b bound to both Con A and LCH
columns, but not to those made from RCA
or WCxA Sepharose. Rejection assays
performed after immunization of mice
with various column fractions revealed
TSTA in the bound fraction of the WGA
column and in the unbound fractions on
Con A, LCH and RCA columns. These
results are presented as growth curves in
Fig. 6, and as antigenic ratios in the
Table. The binding of TSTA to WGA
permits considerable purification in a
single step. Furthermore, by using a com-
bination of Con A and WGA columns,
separation ofTSTA from H-2 and proteins
that can bind to both columns could be
achieved. The individual specificities of
TSTA for 6A or 6B tumours was con-
served in the purified preparations. In
a further experiment, the fraction of
MC6A DOCSOL that did not bind to
T
E
0 5 10 15 5 10 15
c K) C d
m
6A challenge 6B challenge
5 T
5 10 15 5 10 15
DAYS
FIG. 4.-Growth of MC6A and MC6B in mice
immunized witli various preparations.
Groups of 4 mice were immunized by 3
weekly s.e. injections into the right groin
of 107 irradiated cells &; membranes 0,
DOCSOL Fj, each containing the amount
ofH-2hequivalent to 4 x 107 cells. In a and
b, MC6A preparations were the immuno-
gen: in c and d, MC6B preparations. Ten
days after the last immunization the
animals were challenged with 2 x 105
viable MC6A or 6B cells in 0-2 ml PBS s.e.
into the right groin. A group of un-
immunized animals was cliallenged con-
currently, 0. Bars represent s.e. (similar
values for b and c omitted for clarity).
that the detergent extraction provides a
product which is purified with respect to
whole cells. Furthermore there is no
evidence ofextensivedegradation ofeither
proteins or glycoproteins.
TSTA release
Figs. 4 (a-d) show the growth curves
of a challenge tumour, either MC6A
or MC6B, after immunization of the reci-
pient mice with either irradiated whole
cells, membranes or solubilized membranes837 SOLUBILIZATION AND LECTIN BINDING OF SARCOMA TSTA
TABLE.-Immunogenicity of lectin-columv,
fractionated DOCSOL of MC6A and
MC6B -sarcomas
Antigenic ratio on
challenge with
r
MC6A MC6B
1.1 0.9
2-3 1.1
1-2 i-O
1.0 1.9
1.0 0.9
3-2 1-3
N.T. 0.9
N.T. 1-8
1.0 N.T.
1-8 N.T.
N.T. 1.0
N.T. 1-9
1-9 1.0
1.0 0.9
Fraction
Con A bound MC6A Con A unbound
Con A bound MC6B Con A unbound
LCH bound MC6A LCH unbound
LCH bound MC6B LCH unbound
RCA bound MC6A RCA unbound
RCA bound MC6B RCA unbound
WGA bound MC6A WGA unbound
WGA bound MC6B WGA unbound
C-W- MC6A C-W+ f
DAYS
1.9
0.9
N.T.
1-2
1.1
1-2
1.0
3-1
L
comas has been hindered by the lack of
methods forpreparing them in a form suit-
able for comparison with each other and
5 10 15 with
. other cell-surface proteins. This
requires releasing them in good yield
and unbound from the tumour cells in a form that is
GA Sepharose undegraded and retainsthespecificitythey
"6B DOCSOL show on intact cells.
,s fractionated We have shown that the use of a mild :)se. Groups of
4 3 weekly in- detergent in the presence of proteolysis
,ound fractions inhibitor does satisfy the desired criteria. immunization
I with 2X 105 The material released remains antigenic
group of un- in transplantation assays and shows the
,as challenged same specificity as the original tumour. ±s.e.) Whilst it is easy to show serologically that
was run on a H-2 is released in very high yield, it is
i binding to the not possible to make such quantitative
statements about TSTA. We lack antisera
bs then assayed
rejection assay specific for TSTA, though recent experi-
ments on MC murine sarcomas (Parker & Table. Again Rosenberg, 1977; De Leo elal., 1977) show The C- W+ that these might be possible to prepare. refined form of Lacking this, the only assay we used for
TSTA was that of immunizing mice
against tumour challenge. This assay does
not lend itself to the quantitation of
the diverse set TSTA yielded in the various purification
lantation anti- steps. Nonetheless, the PAGE analyses
.y induced sar- seem to indicate that the solubilization
5 10 15
DAYS
FIG. 6.-Protection by bound
fractions from Con A and W(
columns. BlO/MC6A or MC
prepared from 109 cells wai
on Con A and WGA Sepharc
3 mice were immunized witl
jections of bound (A) or unbi
(0). Ten days after the last
the animals were challenge.
autologous tumour cells. A
immunized animals (0) w.
concurrently. (Bars indicate
immobilized Con A (C-)
WGA column. The fraction
latter column (C- W+) wa
for TSTA activity. The i
results are shown in the
specificity is conserved.
fraction is clearly the most
TSTA that we prepared.
DISCUSSION
The characterization of
of tumour-specific transp]
gens (TSTA) of chemicall,V ---838 K. SIKORA, G. KOCH, S. BRENNER AND E. LENNOX
process does not lead to loss ordegradation
ofany ofthe major membraneproteins.
The binding of TSTA to WGA columns
provides a relatively simple procedure for
considerablepurification for the 2 tumours
studied. Itwill beinterestingto seewhether
this feature will hold for other tumours.
In view of the question whether TSTAs
are similar molecules to H-2, their
evident separations on WGA and Con A
columns is ofinterest. While this allows us
to say nothing about the protein moieties
ofthese molecules, it does at least indicate
something about their exposed sugars.
We hope to continue this comparison in
further experiments.
We thank Philip Wright, Pam Gregory, Sue Ingle
and Lorraine Carver for expert assistance. K.S. held
an MRC TrainingFellowship.
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